miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
about
MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for TreatmentEmerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung CancerAdvanced Research on MicroRNAs and EGFR-TKIs Secondary ResistanceMicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivityIntegrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancerExpression, regulation and function of miR-495 in healthy and tumor tissuesSmall RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinomaNo Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma.MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 DeletionPrognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancerMicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cellsAssociation of XRCC3 and XRCC4 gene polymorphisms, family history of cancer and tobacco smoking with non-small-cell lung cancer in a Chinese population: a case-control studyMicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinomaDysfunctions associated with methylation, microRNA expression and gene expression in lung cancerSmoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyUnique microRNA-profiles in EGFR-mutated lung adenocarcinomas.Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.MicroRNA gene dosage alterations and drug response in lung cancerMultiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathwayA novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic valuesCirculating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.Applications of MicroRNAs in the Diagnosis and Prognosis of Lung CancerMechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical ImplicationsPlasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review).Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model.An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.Independent validation test of the vote-counting strategy used to rank biomarkers from published studies.miR-32 inhibits proliferation, epithelial-mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cellsmiR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsSmall cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
P2860
Q26752548-23A2BF69-5FF5-405B-B831-FECDC3142605Q26798147-89B80803-B4D7-45B2-8204-599A9A960BC5Q28069990-3827CA1E-8E43-4E15-9117-F3469E1FB309Q28268506-5AFA2053-9661-4A69-BFA1-0E67A91000CDQ28530422-432D9FEB-700D-4754-9D52-E3EE98B814C5Q33598360-F379BC10-E5AD-4EA7-9F12-2459AEC7C5F1Q33688925-DA4F295C-0B13-462F-B33B-FD269D95862DQ33700748-1CC77ED8-4946-44B5-9653-8998C32BAAF8Q33776774-14976A8E-C32B-4EF6-9658-D2C3ACC114E2Q33961980-9EE60CFE-0F8D-4018-AF16-70F8A7162FFCQ33973612-9C278BBE-A989-4D83-A49B-60F68AB07D98Q34015709-6B492A19-B7EC-4587-809B-FA2AA98E2958Q34203975-0A8AD3F0-0551-4CAD-A17D-1BE0E4191EEBQ34219872-A36D4835-77A5-4C44-B23F-BBCCC6B6FC78Q34389624-254976FC-EA31-4ACE-99CF-D360F84B7620Q34436424-62A09759-F11F-4F1F-8FFE-E3038AA725DEQ34531091-52BB2797-6A8B-4E6D-BF88-D2C82CB75AA4Q34633885-D468E0EB-1478-42C3-98D1-9D2B6D3816FBQ34897598-023A971D-E8AD-4D31-B95A-958876C5F030Q35097232-5725E124-3ACE-4175-87AF-24F915C0BB40Q35101278-0C6DAA60-BEE8-425B-ACFF-D9AD4B1C7BADQ35819328-5E1DC701-CC69-48E2-8E8C-EF5C79CA7D6BQ35835222-7F0D45EA-70AB-44CD-9AD3-43E127475CADQ35897588-0ABCF303-8054-4AD2-90B1-D4E83B246499Q35970795-C09AFCBB-473E-4B1C-BE9A-C05B9ED7C037Q36125057-73F92E3C-C37C-4974-BAFA-21338B9EBEC0Q36170868-52800A1A-73DE-4109-B376-CEFC7296608CQ36299594-FE59D564-F783-4BE2-B8B5-3A2D3E5A2941Q36383144-8B9B9927-4661-457A-8D14-7266D290A3DBQ36411401-0090C527-D3C8-41BF-998D-A2129C289528Q36413478-C18BD551-B973-43E4-83E2-9F98D800ABC7Q36545124-1E749C0A-BA7A-473F-81F0-A146F3DE30B1Q36629665-66551E45-07DF-48B3-889B-0B668C774D64Q36702568-C3B2FC23-704D-402D-82E3-22455CF19DF8Q36785683-D3EC88A5-ECA7-4ABF-B922-1747B90AD549Q37109827-FF2CDF62-BFB5-4360-9976-635E06476CE1Q37286761-30F85B2B-BEEA-4A65-AA84-FC6A5B0692D7Q37290532-9BDF4415-B959-4D5B-9FF1-F05074F14458Q37301705-5E297F9D-6D52-4419-B93E-305111579F55Q37492137-79CDB94B-7D0F-439B-AB15-7A7947E5A7B8
P2860
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@ast
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@en
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@nl
type
label
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@ast
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@en
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@nl
prefLabel
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@ast
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@en
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@nl
P2093
P2860
P1433
P1476
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
@en
P2093
Lindsey Kelly
Marina N Nikiforova
Sanja Dacic
Yongli Shuai
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.152
P577
2010-09-03T00:00:00Z
P5875
P6179
1041902056